moxisylyte has been researched along with Chronic Disease in 5 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We compared the efficacy and safety of alprostadil alpha-cyclodextrin and moxisylyte chlorhydrate to induce erections adequate for sexual intercourse in a prospective, randomized, parallel double-blind study in patients with erectile dysfunction." | 9.08 | Double-blind multicenter study comparing alprostadil alpha-cyclodextrin with moxisylyte chlorhydrate in patients with chronic erectile dysfunction. ( Albrecht, D; Buvat, J; Costa, P; Lecocq, B; Morlier, D; Stegmann, B, 1998) |
| "We compared the efficacy and safety of alprostadil alpha-cyclodextrin and moxisylyte chlorhydrate to induce erections adequate for sexual intercourse in a prospective, randomized, parallel double-blind study in patients with erectile dysfunction." | 5.08 | Double-blind multicenter study comparing alprostadil alpha-cyclodextrin with moxisylyte chlorhydrate in patients with chronic erectile dysfunction. ( Albrecht, D; Buvat, J; Costa, P; Lecocq, B; Morlier, D; Stegmann, B, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vittori, C | 1 |
| Galbussera, M | 1 |
| Salvini, M | 1 |
| Terraneo, F | 1 |
| Ragni, F | 1 |
| Buvat, J | 1 |
| Costa, P | 1 |
| Morlier, D | 1 |
| Lecocq, B | 1 |
| Stegmann, B | 1 |
| Albrecht, D | 1 |
| Wilensky, MC | 1 |
| Sjaastad, O | 1 |
| Aasly, J | 1 |
| Fredriksen, T | 1 |
| Wysocka Bakowska, MM | 1 |
| Astin, TW | 1 |
1 trial available for moxisylyte and Chronic Disease
| Article | Year |
|---|---|
Double-blind multicenter study comparing alprostadil alpha-cyclodextrin with moxisylyte chlorhydrate in patients with chronic erectile dysfunction.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; alpha-Cyclodextrins; Alprostadil; Chronic Disease; Cyclod | 1998 |
4 other studies available for moxisylyte and Chronic Disease
| Article | Year |
|---|---|
[Therapeutic effects of an alpha-blocker in chronic organic and functional arteriopathy of the limbs].
Topics: Adolescent; Adult; Aged; Arterial Occlusive Diseases; Chronic Disease; Extremities; Female; Humans; | 1982 |
Curent concepts in primary angle-closure glaucoma.
Topics: Acetazolamide; Acute Disease; Chronic Disease; Glaucoma; Glycerol; Humans; Mannitol; Moxisylyte | 1977 |
Chronic paroxysmal hemicrania. X. On the autonomic involvement.
Topics: Atropine; Autonomic Nerve Block; Autonomic Nervous System; Bupivacaine; Chronic Disease; Cornea; Fem | 1986 |
Bronchial sympathetic activity in chronic bronchitis.
Topics: Airway Resistance; Bronchitis; Chronic Disease; Humans; Injections, Intravenous; Male; Middle Aged; | 1972 |